6657 fundamentals
An in-depth look to ENERGENESIS BIOMEDICAL CO LTD operating, investing, and financing activities
6657 free cash flow for Q4 24 is -32.1 M TWD. For 2024, 6657 free cash flow was -181.47 M TWD and operating cash flow was -180.71 M TWD.
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: TWD
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
TTM